10.4244/EIJV9I4A72
•
Aug 23, 2013
Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2
Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T
free
10.4244/EIJV9I4A73
•
Aug 23, 2013
Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery
Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H
free
10.4244/EIJV9I4A74
•
Aug 23, 2013
Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries
Moynagh A, Salvatella N, Harb T, Darremont O, Boudou N, Dumonteil N, Lefèvre T, Carrié D, Louvard Y, Leymarie J-L, Chevalier B, Morice M, Garot P
free
10.4244/EIJV9I4A78
•
Aug 23, 2013
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry
Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe U, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump L, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G
free
10.4244/EIJV9I3A52
•
Jul 26, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco DJ, Dawkins K
free
Showing
3751
to
3765
of
5330
results
